A real-world single-centre analysis of alemtuzumab and cladribine for multiple sclerosis
Gauruv Bose, Carolina Rush, Harold Atkins, Mark S. Freedman
Topics & Concepts
CladribineMedicineAlemtuzumabMultiple sclerosisExpanded Disability Status ScaleInternal medicineAdverse effectRegimenClinical trialTransplantationImmunologyMultiple Sclerosis Research StudiesPolyomavirus and related diseasesMultiple Myeloma Research and Treatments